Portfolio of 18 primary care drugs, both over-the-counter and prescription, sold across the Asia Pacific region.
Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio covers 18 primary care products, both over-the-counter and prescription, sold in Australia, Hong Kong, Macau, Malaysia, the Philippines, Singapore, South Korea, Taiwan and Thailand. The portfolio is based in Chuo-ku, Japan. In January 2024, CBC Group and Dong-A Socio Holdings acquired it from Celltrion, Inc. for KRW 247.1 billion.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign inWork at Takeda Pharmaceutical Company Limited's Asia Pacific Primary Care Portfolio? This is my company